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The emphasis of care is to delay the pro-bination of gentamicin with carbenicillin in a crossover study in which saline was used as the gression of pulmonary sepsis which is responsible for almost the total mortality of placebo. 6 Each arm of the crossover period lasted for four months. Both active drug repatients with cystic fibrosis. Repeated sputum culture of P aeruginosa confirms chronic in-gimens were equally effective in increasing body weight and improving lung function compared fection and it is then impossible to eradicate. Regular courses of intravenous antibiotics have with placebo. These results suggest that only one nebulised antibiotic is required for efficacy. improved survival by reducing sputum load and maintaining pulmonary function, but they A recent short term study recruited 71 patients into a controlled trial of placebo versus interfere with the activities of daily living. The prescription of nebulised antibiotics for dom-high dose nebulised tobramycin, 600 mg/day. 7 The high dose of tobramycin was used to iniciliary use by patients with cystic fibrosis is increasing. However, experienced physicians crease the bactericidal dose of antibiotic in the sputum against tobramycin sensitive P aeruworking in cystic fibrosis centres have shown considerable variability in their prescribing ginosa. There was a significant improvement in pulmonary function and a reduction of P practices.
2 aeruginosa in the sputum. Bacterial resistance patterns were similar during the active and placebo part of the study. No ototoxicity or nephrotoxicity was observed. These results sugClinical indications gest that high dose nebulised tobramycin is      clinically effective, safe, and does not promote   P AERUGINOSA bacterial resistance. The introduction of nebulised colistin at the Nebulised tobramycin, 80 mg twice daily, time of initial colonisation with P aeruginosa was evaluated in a long term open study (mean may reduce and delay chronic colonisation, 3 4 duration 20 months) in 14 patients with a defined as three consecutive positive sputum mean age of 13.3 years. 8 Clinical parameters cultures within six months. In an uncontrolled improved and hospital admissions decreased. trial nebulised colistin given to seven children There was a reduction in one or more inwith cystic fibrosis reduced the frequency of flammatory markers (antibody serum titres positive cultures from 46% to 6%.
3 In a conto P aeruginosa, elastase, exotoxin A, alkaline trolled prospective study a combination of phosphatase) in eight patients. No tobramycin nebulised colistin and oral ciprofloxacin sigwas detected in 50 of 70 blood samples. Innificantly prevented or delayed chronic intermittent tobramycin resistance developed in fection with P aeruginosa for 18 months. 4 These five patients (but only in 6.2% of strains) and results suggest a role for nebulised antibiotics persisted in only one patient at the end of the when the organism is first isolated from spustudy. These results suggest that long term tum. No trials have been published on the use nebulised aminoglycosides are safe, clinically of nebulised antibiotics at the time of diagnosis effective and, by reducing the bacterial antigen of cystic fibrosis before P aeruginosa has been load, may diminish the systemic host immune cultured from the sputum.
response. A review of five randomised controlled trials showed benefit for nebulised antipseudomonal antibiotic therapy with no demonstrable ad-     verse effects. 9 There is no evidence to suggest     that nebulised antibiotics used as an adjunct
to a course of intravenous antibiotics augment Regular aerosolised antibiotics have been used clinical improvement.
10 Nebulised antibiotics for patients chronically infected with P aeru-should not be used as an alternative to intraginosa to reduce the rate of deterioration. An A recent sputum culture should be used to 12 13 Prevention of bronchoconstriction 2 mega units 4 ml 2 ml water+2 ml 0.9% NaCl may be achieved by altering the tonicity by 2 mega units 2.5 ml 1.5 ml water+1 ml 0.9% NaCl 2 mega units 3 ml 2 ml water+1 ml 0.9% NaCl dilution with water or half normal saline.
14 It is recommended that patients use nebulised antibiotics after physiotherapy and bronchodilators to ensure maximum deposition and protection from bronchoconstriction.
11 Patients should be provided with a Nebulised antibiotics are prescribed twice a day for domiciliary use. Drugs and dosages are mouthpiece rather than a face mask to maximise pulmonary deposition. 15 Relaxed tidal presented in tables 1 and 2. volume breathing through the mouth and not the nose 16 is recommended for patients using nebulised antibiotics. Finally, patient com-  Resistance pliance levels should be checked after a period of domiciliary use. Irregular usage is not re-Concern has been expressed that bacterial resistance will develop with the administration commended and is a reason for cessation.
of sublethal twice daily doses of aerosolised antibiotics. Resistance does occur but is often intermittent and not related to clinical deterioration. 5 8 There is no confirmatory evi-       dence that the use of aerosolised antibiotics in the presence of resistant bacteria leads to Overall, about 10% of a nebulised drug is delivered to the lungs. A study in volunteers increased colonisation of the bronchial tree with these resistant organisms. Burkholderia ceand five mechanically ventilated patients given 300 mg nebulised tobramycin found that 5.5% pacia is always resistant to colistin which should not be used if it is the only pathogen in the of the initial dose was excreted in the urine of both groups. A piece of normal lung tissue was sputum. There is no published literature on the use of nebulised antibiotics for B cepacia. removed from the ventilated patients who were undergoing thoracotomy and mean concentrations of 5.5 g/g and 3.6 g/g were found at four and 12 hours. 17 
Environmental safety
Concern has been expressed that the liberal Systemic absorption of nebulised aminoglycosides does occur in patients but the use of nebulised antibiotics may be a health hazard to medical personnel and constitute a amount absorbed proportional to the dose delivered as measured by urinary excretion is threat to the hospital and home environment.
Staff caring for patients using nebulised antismall (0.5%).
18
Although the concentration of aerosolised biotics have experienced bronchoconstriction and cutaneous rashes. Although it has been antibiotic in bronchial secretions may not always achieve bactericidal levels, sublethal con-suggested that polluting the hospital atmosphere may lead to the establishment of centrations may diminish bacterial virulence factors. 19 resistant organisms, particularly on intensive care units where patients may receive nebulised antibiotics following transplantation to maintain airways sterility, there is no published medical evidence to support this.      The polymyxin antibiotic colistin and the In hospital a nebuliser should be fitted with a high efficiency breathing filter on the expiratory aminoglycosides tobramycin and gentamicin are the most commonly prescribed nebulised port to prevent environmental contamination and patients with cystic fibrosis can usually antibiotics. Colistin is currently the only antibiotic licensed in the UK for inhalation. Tobra-stop their nebulised antibiotics when they are receiving intravenous antibiotics. It is advisable mycin probably has greater activity than gentamicin against P aeruginosa. Infrequently for patients to receive them in a separate area.
At home patients should nebulise their antiused antibiotics for nebulisation include ceftazidime, carbenicillin, and ticarcillin. Colistin biotics in a separate room. They do not need to vent their exhaled antibiotics for safety reasons has excellent antipseudomonal activity and is probably the first line choice for nebulised use. although they may wish to do so to eliminate the odour. If they have a sibling with cystic Pseudomonas aeruginosa resistance is rare but Burkholderia cepacia resistance is total.
fibrosis they should use a filter.
effective delivery of the nebulised antibiotic to is used the face should be washed after anti- sequently by patients infected with P aeruginosa.
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